PortViewPortView
Cardio Diagnostics logo

Cardio Diagnostics (CDIO) Stock Analysis

NASDAQHealthcareBiotechnology

$1.89+2.16%
1-year price historyRange $1.05 – $6.55
52-week range$1.89
$0.97$7.91

What Cardio Diagnostics does

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

Key metrics

Market cap
$5.59M
P/E (TTM)
-0.65
EPS (TTM)
$-2.92
Beta
2.22
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$1.85
200-day avg
$2.30
52-week high
$7.91
52-week low
$0.97
CEO
Meeshanthini V. Dogan

ETFs linked to CDIO

Broad-market and Healthcare sector ETFs an investor holding Cardio Diagnostics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CDIO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CDIO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Cardio Diagnostics?
Cardio Diagnostics trades under the ticker CDIO on NASDAQ.
Which exchange is CDIO listed on?
CDIO is listed on NASDAQ.
What sector does Cardio Diagnostics operate in?
Cardio Diagnostics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CDIO in a portfolio?
PortView shows CDIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.